Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and September 2017

Showing 1 to 10 of 353
Title Reference number Published Last updated
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy Reference number:TA428 TA00428 Published:January 2017 20170101 Last updated:September 2017 20170912
Pembrolizumab for advanced melanoma not previously treated with ipilimumab Reference number:TA366 TA00366 Published:November 2015 20151101 Last updated:September 2017 20170912
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab Reference number:TA357 TA00357 Published:October 2015 20151001 Last updated:September 2017 20170912
Sorafenib for treating advanced hepatocellular carcinoma Reference number:TA474 TA00474 Published:September 2017 20170901 Last updated:September 2017 20170906
Dimethyl fumarate for treating moderate to severe plaque psoriasis Reference number:TA475 TA00475 Published:September 2017 20170901 Last updated:September 2017 20170906
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer Reference number:TA476 TA00476 Published:September 2017 20170901 Last updated:September 2017 20170906
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck Reference number:TA473 TA00473 Published:August 2017 20170801 Last updated:August 2017 20170831
Eluxadoline for treating irritable bowel syndrome with diarrhoea Reference number:TA471 TA00471 Published:August 2017 20170801 Last updated:August 2017 20170830
Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab Reference number:TA472 TA00472 Published:August 2017 20170801 Last updated:August 2017 20170830
Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal) Reference number:TA468 TA00468 Published:August 2017 20170801 Last updated:August 2017 20170823